Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Benlifang Pharmaceutical Technology is a China-based biotechnology company focused on the research, development, and technical service of innovative pharmaceutical products. The company specializes in the synthesis of high-end pharmaceutical intermediates and active pharmaceutical ingredients (APIs), particularly focusing on small molecule drug discovery. Their business model encompasses both internal drug development programs and contract research services for global pharmaceutical partners. Chongqing Benlifang aims to provide high-quality chemical solutions to accelerate the drug development process in therapeutic areas such as oncology and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Benlifang Pharmaceutical Technology.